TCL Archive Also in this 8-page issue: House Committee on Energy and Commerce is investigating the collapse of the Institute for Cancer Prevention, which owes $5.7 million to NCI. December 3, 2004
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
